Skip to main content
. 2021 Feb 13;13(2):258. doi: 10.3390/pharmaceutics13020258

Table 7.

Amount of permeated and accumulated BVZ after 24 h, expressed as a percentage, through the cornea, released from the ME systems under study.

Sample % Diffused BVZ in 24 h % Accumulated BVZ in 24 h
BVZ solution (Avastin®) 0.40 ± 0.11 5.16 ± 0.66
M2 0.56 ± 0.09 15.24 ± 0.95
LC2 0.70 ± 0.11 19.89 ± 0.83
PL2 1.56 ± 0.09 4.08 ± 0.37